Enter Note Done
Go to previous page in this tab
Session
  • Presentation | General Poster Session - Sunday General Poster Session
  • General Poster Session
  • Share Icon
    Map Icon
    Bookmark Icon
  • 1712-P - Benefits of HR17031 vs. Insulin Glargine (iGlar) in Patients (pts) with Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) and Metformin [Board No. 1712]
    • Schedule
    Notes
  • 1712-P
    Set Timezone
    •  
    Route Me

L. Chen: Research Support; Current; AstraZeneca, Lilly, Gan & Lee Pharmaceuticals, Novo Nordisk, Sanofi. Q. Zhang: None. N. Mi: None. J. Zhang: None. W. Hu: None. G. Li: None. T. Lei: None. Z. Ye: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd. Q. Zhou: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd. T. Xu: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd. X. Yang: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd..
Type
Main Session